I know -- it is TheStreet.com, talking here -- but it is intriguing (despite being a Jim Cramer property):
. . . .China Sky is set to report earnings of $2.41 a share for 2010, according to consensus estimates of analysts polled by Bloomberg. In comparison, Pfizer and Merck are likely to report earnings of $1.56 a share and $2.38 a share, respectively, for 2010. . . .
TheStreet is making the case that China's pharma companies may be a more compelling value that either Pfizer or Merck. Just so you know.
2 comments:
China Sky One is worth about 200 million in market cap and MRK and PFE about 100 BILLION ea. Its like comparing a major US/EU pharma to a vitamin manufacture. It is like comparing a value stock to a growth stock, apples to oranges, chocolate vs white milk, etc.. Also, how do you trust chinese stocks to have reported all debt, funding, shares, bonds, etc.. I don't trust. Now can you make money, surely.
I agree -- I posted it for comedic effect. Actually, it was an excuse to make a oool lil' graphic(!).
More seriously, though -- my general rule is to do the opposite of whatever Cramer says on pharma, biotech or healthcare names.
He has no instinct, nor intuition -- about these matters -- and even less hard experience.
Thanks for the thoughts! Do stop back.
Namaste
Post a Comment